Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
about
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@en
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@nl
type
label
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@en
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@nl
prefLabel
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@en
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
@nl
P2093
P356
P1476
Sorafenib combined with TACE in advanced primary hepatocellular carcinoma
@en
P2093
Guang-hai Dai
Han-zhi Cui
P304
P356
10.5754/HGE12552
P50
P577
2013-03-01T00:00:00Z